7Baggers
 collegium pharmaceutical (nasdaq:coll) upgraded at zacks research  MarketBeat Fri, 26 Sep 2025 11:11:21 GMT
 1 russell 2000 stock to research further and 2 we avoid  The Globe and Mail Fri, 26 Sep 2025 04:31:00 GMT
 About Us  FinancialContent Thu, 25 Sep 2025 03:31:00 GMT
 Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?  sharewise.com Tue, 23 Sep 2025 17:08:58 GMT
 are medical stocks lagging argenx (argx) this year?  Yahoo Finance Tue, 23 Sep 2025 07:00:00 GMT
 published on: 2025-09-16 22:00:53  خودرو بانک Tue, 16 Sep 2025 18:31:42 GMT
 amundi raises stake in collegium pharmaceutical, inc. $coll  MarketBeat Mon, 15 Sep 2025 07:13:48 GMT
 1 safe-and-steady stock to keep an eye on and 2 facing headwinds  Yahoo Finance Fri, 12 Sep 2025 07:00:00 GMT
 published on: 2025-08-30 07:31:16  sundaytimes.kr Fri, 29 Aug 2025 22:32:16 GMT
 Collegium to Participate in Upcoming Investor Conferences  GlobeNewswire Thu, 28 Aug 2025 07:00:00 GMT

Collegium Pharmaceutical, Inc
(NASDAQ:COLL) 

COLL stock logo

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immedia...

Founded: 2002
Full Time Employees: 255
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic

Share this website to your friends